These results suggested the possibility of GLP-1 as a treatment for diabetes, but limitations for therapeutic utility existed as endogenous GLP-1 had a short half-life in plasma of 1 to 2 minutes, degraded by the dipeptidyl-peptidase 4 (DPP-4) enzyme [13]
According to researchers from Johns Hopkins, women who take GLP-1 RAs lose an average of 11% of their starting weight after 43 weeks of treatment
Este medicamento puede causar efectos secundarios, como nuseas/vmitos, diarrea, estreimiento, dolor abdominal, dispepsia, reacciones en el lugar de la inyeccin, fatiga, reacciones de hipersensibilidad, gases, cada del cabello, ERGE, distensin abdominal, mareos e hipotensin
Make sure you stick to a regular dosing schedule and take your levothyroxine on an empty stomach
So consistent with the literature, you can expect when deploying low cost behavioral interventions that a subset of patients usually around twenty to twenty five percent can lose clinically meaningful weight